NR1H4 and serum lipopolysaccharide activity: Furthermore, obeticholic acid and other FXR agonists restore microbiota composition, enhance intestinal innate defenses, mitigate intestinal inflammation, and lower bacterial translocation and endotoxemia in experimental cirrhosis [55,90,91].